CJC-1295
CJC-1295 - 10mg x 10 (2ml) vials
Explore the research potential of CJC-1295 (No DAC), a synthetic analogue of growth hormone-releasing hormone (GHRH) . Also known as Modified GRF (1-29), this peptide is primarily studied for its ability to selectively bind to GHRH receptors and stimulate the pulsatile release of growth hormone (GH) . Unlike the DAC-conjugated version, this variant has a shorter half-life, allowing researchers to investigate more immediate and controlled GH-axis dynamics in preclinical models .
This 5mg vial is supplied as a lyophilized (freeze-dried) powder, ensuring maximum stability and peptide integrity. Ideal for researchers studying endocrine pathways, metabolic regulation, and receptor signaling mechanisms .
-
Product: CJC-1295 (No DAC) / Modified GRF (1-29)
-
Quantity: 10mg x 10 (2ml) vials
-
Form: Lyophilized Powder
For research use only. Not for human consumption.